The method has been validated for detecting an inflammatory factor, human interleukin-6 (human IL-6), and a tumor marker, human vascular endothelial growth factor (human VEGF), with LODs of 45.81 and 32.27 fg/ml, respectively, thereby achieving a hundredfold improvement in LOD. This evidence concerns the gene IL6 and neoplasm.